Cost-effectiveness of cadaveric and living-donor liver transplantation

Transplantation

Volumn 73, Issue 4, 2002, Pages 616-622

  Sagmeister, Markus ^a   Mullhaupt, Beat ^a   Kadry, Zakiyah ^a   Kullak Ublick, Gerd A ^a   Clavien, Pierre A ^a   Renner, Eberhard L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MODEL; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037181093     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202270-00025     Document Type: Article

References (46)

1. Swisstransplant
2. Liver transplantation
3. Expanding the donor pool for liver transplantation
4. Selection of donors and recipients for living donor liver transplantation
5. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe
6. Complications in 100 living-liver donors
7. Cost-effectiveness of liver transplantation
8. Clinical economics review: Liver transplantation
9. An economic analysis of liver transplantation. Costs, insurance coverage, and reimbursement
10. Resource utilization in liver transplantation: Effects of patient characteristics and clinical practice
11. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B
12. Survival and prognostic indicators in compensated and decompensated cirrhosis
13. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
14. Compensated cirrhosis: Natural history and prognostic factors
15. European Transplantation Registry
16. A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making
17. Evaluation of 100 patients for living donor liver transplantation
18. Living donor liver transplantation in adults: Outcome in Europe
19. Living donor liver transplantation in adults: Outcome in Japan
20. Right-lobe living donor liver transplantation
21. Long-term complications of living donor liver transplantation
22. Preferences for health outcomes. Comparison of assessment methods
23. A pragmatic and costeffective strategy of a combination therapy with alfa 2b interferon and ribavirin for the treatment of chronic hepatitis C
24. Assessment of the quality of life before and following liver transplantation. First results
25. Outcomes analysis for 50 liver transplant recipients: The Vanderbilt experience
26. Outcomes analysis in 100 liver transplantation patients
27. Health-related quality of life after different types of solid organ transplantation
28. Survival and prognostic factors of cirrhotic patients with ascites: A study of 134 outpatients
29. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
30. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study
31. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare
32. Selection and outcome of living donors for adult to adult right lobe transplantation
33. Cost-effectiveness analysis of the Dutch liver transplantation programme
34. Costs and outcomes of liver transplantation in adults: A prospective, 1-year, follow-up study
35. Results with living donor liver transplantation in Germany
36. Transplantation of liver grafts from living donors into adults-too much, too soon
37. Evaluating the potential cost-effectiveness of stenting as a treatment for symptomatic single-vessel coronary disease. Use of a decision-analytic model
38. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease